A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma

NCT06071871 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Large B-cell Lymphoma

Interventions

DRUG: Glofitamab
DRUG: Polatuzumab vedotin
DRUG: Obinutuzumab

Sponsor

University College, London

Collaborators

[object Object]